Search research articles
Contact Us
Filters
Showing results (271-280 of 376) with videos related to
Page
of 38
Sort By:
British Journal of Haematology
|
October 3, 2002
CD106 and activated-CD29 are expressed on myelomatous bone marrow plasma cells and their downregulation is associated with tumour progression
Rosario Luque, José Antonio García-Trujillo, Carmen Cámara, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, et al.
Journal of Drugs in Dermatology : JDD
|
January 10, 2022
Alteration to the Skin Ceramide Profile Following Broad-Spectrum UV Exposure
Rebecca Barresi, Hawasatu Dumbuya, I-Chien Liao, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 23, 2009
The search for responsive clinical endpoints in primary progressive multiple sclerosis
L V A E Bosma, J J Kragt, L Brieva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 22, 2010
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
L V A E Bosma, J J Kragt, L Brieva, et al.
Molecular Neurobiology
|
June 17, 2026
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis
Pascual Torres, Anna Gil Sánchez, Agustín Sancho-Saldaña, et al.
Seminars in Oncology
|
December 18, 2020
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Winston Wong, Claire Brieva, Michael May, et al.
Neurodegenerative Disease Management
|
May 10, 2021
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies
José Meca-Lallana, Juan Antonio García-Merino, Sergio Martínez-Yélamos, et al.
International Immunopharmacology
|
May 26, 2005
AM3 inhibits LPS-induced iNOS expression in mice
Pedro Majano, José Luis Alonso-Lebrero, Agnieszka Janczyk, et al.
Medicina Clinica
|
February 10, 1996
[Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation]
C Parra, E Roldán, C Rodríguez, et al.
Page
of 38
Search research articles
Search
Showing results (271-280 of 376) with videos related to
Sort By:
Page
of 38
British Journal of Haematology
|
October 3, 2002
CD106 and activated-CD29 are expressed on myelomatous bone marrow plasma cells and their downregulation is associated with tumour progression
Rosario Luque, José Antonio García-Trujillo, Carmen Cámara, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, et al.
Journal of Drugs in Dermatology : JDD
|
January 10, 2022
Alteration to the Skin Ceramide Profile Following Broad-Spectrum UV Exposure
Rebecca Barresi, Hawasatu Dumbuya, I-Chien Liao, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 23, 2009
The search for responsive clinical endpoints in primary progressive multiple sclerosis
L V A E Bosma, J J Kragt, L Brieva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 22, 2010
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
L V A E Bosma, J J Kragt, L Brieva, et al.
Molecular Neurobiology
|
June 17, 2026
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis
Pascual Torres, Anna Gil Sánchez, Agustín Sancho-Saldaña, et al.
Seminars in Oncology
|
December 18, 2020
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Winston Wong, Claire Brieva, Michael May, et al.
Neurodegenerative Disease Management
|
May 10, 2021
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies
José Meca-Lallana, Juan Antonio García-Merino, Sergio Martínez-Yélamos, et al.
International Immunopharmacology
|
May 26, 2005
AM3 inhibits LPS-induced iNOS expression in mice
Pedro Majano, José Luis Alonso-Lebrero, Agnieszka Janczyk, et al.
Medicina Clinica
|
February 10, 1996
[Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation]
C Parra, E Roldán, C Rodríguez, et al.
Page
of 38